Press release
Chronic Lower Back Pain Market Size, Share and Growth Report, 2034
Chronic Lower Back Pain Market
Chronic lower back pain (CLBP) is one of the most common and debilitating conditions worldwide, affecting millions of individuals and significantly impacting their quality of life. Defined as pain that persists for more than 12 weeks, CLBP can result from various causes, including degenerative disc disease, muscle strain, sciatica, herniated discs, and spinal stenosis. With the aging population, increased sedentary lifestyles, and growing prevalence of obesity and poor posture, the incidence of CLBP continues to rise, making it a major healthcare concern.
The chronic lower back pain market is expanding rapidly due to the increasing demand for effective treatments and the ongoing advancements in pain management therapies. From non-invasive options such as physical therapy and medications to minimally invasive surgical procedures, the market is witnessing innovations in treatment modalities, driving growth across a wide range of therapeutic options. In addition, with the rise of personalized treatments and interventional techniques, the market is evolving toward more targeted pain management solutions.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/70977
Market Overview
• Market Size 2024: USD 10.2 billion (estimated)
• Forecast 2034: USD 24.5 billion
• CAGR (2024-2034): ~9.1%
The chronic lower back pain market is poised for significant growth, driven by an increase in patient demand for effective pain relief solutions and the rising prevalence of chronic conditions associated with back pain. Additionally, technological advancements in medical devices, surgical interventions, and pain management therapies are improving patient outcomes, enhancing the market's growth prospects. With an increasing focus on non-invasive treatments, personalized therapies, and the adoption of robotic surgeries, the chronic lower back pain market is set to continue expanding through 2034.
Key Growth Drivers
• Growing incidence of chronic lower back pain, driven by aging populations, lifestyle changes, and the rise in sedentary habits.
• Advancements in non-invasive therapies, such as physical therapy, epidural steroid injections, radiofrequency ablation, and transcutaneous electrical nerve stimulation (TENS), which offer effective pain relief with minimal side effects.
• The increasing use of minimally invasive procedures, including robot-assisted surgeries and endoscopic disc surgeries, which offer faster recovery times and reduced surgical risks.
• Personalized treatment approaches, including genetic research, biomarker identification, and patient-specific therapies, are enabling targeted pain management and improving long-term outcomes for individuals with chronic lower back pain.
• Growing demand for combination therapies that integrate pharmacologic, physical therapy, and interventional treatments for enhanced pain relief.
Key Challenges
• High treatment costs, particularly for surgical interventions and advanced medical devices, which may limit access for some patients, especially in developing countries.
• Limited availability of trained professionals and specialized care centers for advanced pain management techniques, hindering access to state-of-the-art treatments.
• Side effects of long-term use of pain medications, including opioids, leading to concerns over dependency, and increasing regulatory pressure on prescribing practices.
• Geographic disparities in healthcare access, particularly in low-income regions or rural areas, where advanced spinal surgery and pain management therapies may not be readily available.
Leading Players
• Medtronic
• AbbVie Inc.
• Johnson & Johnson
• Boston Scientific Corporation
• Stryker Corporation
• GlaxoSmithKline
• Pfizer Inc.
• Baxter International Inc.
• Meda Pharmaceuticals (Mylan)
• Cymedica Orthopedics
These companies are leading the development of medications, medical devices, surgical solutions, and minimally invasive therapies to treat chronic lower back pain. Their focus on clinical trials, regulatory approvals, and global market penetration is driving the growth of the chronic lower back pain market, improving patient outcomes, and offering new pain relief options.
Segmentation Analysis
By Treatment Type
• Medications
o Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
o Opioids (for Severe Pain)
o Muscle Relaxants
o Antidepressants (for Neuropathic Pain)
o Topical Analgesics
• Physical Therapy
o Manual Therapy
o Exercise Therapy
o Posture Correction
o Strengthening Exercises
• Invasive Procedures
o Spinal Injections (Epidural Steroid, Nerve Blocks)
o Radiofrequency Ablation
o Spinal Cord Stimulation (SCS)
• Surgical Treatments
o Minimally Invasive Spine Surgery
o Endoscopic Discectomy
o Spinal Fusion Surgery
o Robotic Spine Surgery
By Platform
• Hospitals & Surgical Centers
• Outpatient Clinics
• Pain Management Centers
• Rehabilitation Clinics
• Home Care Settings (for Physical Therapy & Pain Management)
By Technology
• Robotic-Assisted Surgery
• 3D Imaging (For Spinal Diagnosis and Planning)
• Spinal Cord Stimulation (SCS) Devices
• Low-Level Laser Therapy (LLLT)
• Radiofrequency Technology
By End Use
• Pediatric Patients (Rare Cases of Chronic Lower Back Pain)
• Adult Patients (Most Prevalent in Ages 30-60)
• Geriatric Patients (Due to Osteoarthritis, Degenerative Disc Disease)
By Application
• Degenerative Disc Disease
• Spinal Stenosis
• Herniated Discs
• Sciatica
• Muscle Strain and Ligament Sprains
• Chronic Pain Syndromes (Including Neuropathic Pain)
Summary:
The chronic lower back pain market is primarily segmented into medications, physical therapy, invasive procedures, and surgical treatments. Medications such as NSAIDs and opioids are commonly prescribed for managing pain, while physical therapy plays a key role in rehabilitation. Invasive procedures like spinal injections and radiofrequency ablation offer relief for severe pain, while surgical treatments such as spinal fusion and robotic spine surgery address the root cause of chronic back pain. Robotic-assisted surgery and spinal cord stimulation devices are gaining popularity for their precision and minimally invasive nature.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/70977/chronic-lower-back-pain-market
Regional Insights
North America
• Largest market share, driven by high healthcare expenditure, increasing chronic lower back pain prevalence, and advanced healthcare infrastructure.
• US leads the market, with widespread adoption of minimally invasive procedures and robot-assisted surgeries.
• Growing acceptance of personalized treatments, including spinal cord stimulation and radiofrequency ablation, is driving further growth in the region.
Europe
• Strong market presence in Germany, France, Italy, and the UK, where interventional pain management therapies are becoming standard.
• Increased focus on physical therapy and rehabilitation, with posture correction and strengthening exercises gaining traction across the region.
• Clinical research on robotic-assisted spine surgery and spinal cord stimulation is expanding in Switzerland, Germany, and the UK.
Asia-Pacific
• Fastest-growing market, particularly in China, India, and Japan, driven by the rise in aging populations, increasing healthcare spending, and growing demand for non-invasive treatments.
• China is rapidly expanding healthcare infrastructure and adopting advanced technologies for chronic lower back pain management.
• Japan remains a leader in robot-assisted spine surgery, while India is focusing on affordable pain management solutions for a large population.
Middle East & Africa
• Slow market growth due to limited healthcare access in some regions, although countries like UAE and Saudi Arabia are investing in state-of-the-art pain management solutions.
• South Africa is emerging as a key market for chronic lower back pain management, with increased demand for rehabilitation and non-invasive treatments.
Latin America
• Brazil and Mexico are increasing access to healthcare and improving availability of pain management therapies.
• Economic barriers remain, but private-sector investments are improving access to advanced treatments for chronic pain.
Summary:
North America continues to dominate the chronic lower back pain market, while Asia-Pacific is experiencing rapid growth driven by improving healthcare access and rising demand for non-invasive treatments. Europe is leading in clinical trials and advanced technologies for pain management, while MEA and Latin America are gradually increasing access to chronic pain therapies through public-private collaborations.
Market Dynamics
Key Growth Drivers
• Rising prevalence of chronic lower back pain due to aging populations, sedentary lifestyles, and obesity, leading to a higher demand for pain relief treatments.
• Advancements in non-invasive treatments, such as epidural steroid injections, radiofrequency ablation, and spinal cord stimulation, are providing patients with effective alternatives to surgery.
• Technological innovations in robotic-assisted surgery, 3D imaging, and minimally invasive procedures, which reduce recovery times and improve patient outcomes.
• Growing acceptance of personalized treatments, including tailored pain management and patient-specific interventions, leading to better management of chronic lower back pain.
Key Challenges
• High treatment costs, particularly for advanced procedures such as robot-assisted surgeries and spinal cord stimulation, which may limit accessibility in low-income regions.
• Risk of complications associated with surgical treatments, including infection, nerve damage, and recurrent pain, which may affect patient recovery and long-term outcomes.
• Limited availability of skilled professionals and specialized care centers, especially in rural areas or developing regions, which may delay access to advanced treatments.
Latest Trends
• The increasing use of robotic-assisted surgeries and minimally invasive techniques that enable more precise procedures with shorter recovery times.
• 3D imaging and AI-driven diagnostic tools to personalize chronic pain management, offering more accurate treatment plans based on individual symptoms and clinical data.
• Stem cell therapies and regenerative medicine approaches are emerging as potential solutions for long-term pain relief and joint regeneration in chronic lower back pain patients.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=70977
Competitive Landscape
Key Players
• Medtronic
• AbbVie Inc.
• Johnson & Johnson
• Boston Scientific Corporation
• Stryker Corporation
• GlaxoSmithKline
• Pfizer Inc.
• Baxter International Inc.
• Meda Pharmaceuticals (Mylan)
• Cymedica Orthopedics
Competitive Landscape Analysis:
The chronic lower back pain market is highly competitive, with Medtronic, AbbVie, and Johnson & Johnson leading in pain management devices, robot-assisted spine surgeries, and spinal cord stimulation. Companies like Boston Scientific and Stryker are at the forefront of minimally invasive procedures and implantable devices for pain relief. As demand for non-invasive treatments and personalized pain management grows, competition is expected to intensify, with innovative technologies and AI-driven solutions gaining prominence.
Conclusion
The chronic lower back pain market is expected to grow from USD 10.2 billion in 2024 to USD 24.5 billion by 2034, representing a CAGR of 9.1%.
• Opportunities lie in innovations such as robot-assisted surgeries, personalized pain management, and minimally invasive treatments.
• North America remains the dominant market, while Asia-Pacific is set to experience rapid growth.
• Technological advancements and regenerative medicine will continue to drive market innovation and improve patient outcomes.
With advancements in robot-assisted surgery, minimally invasive treatments, and personalized care, the chronic lower back pain market is set to transform pain management and improve the quality of life for millions of individuals globally.
This report is also available in the following languages : Japanese (慢性腰痛市場), Korean (만성 요통 시장), Chinese (慢性下背痛市场), French (Marché des lombalgies chroniques), German (Markt für chronische Schmerzen im unteren Rücken), and Italian (Mercato del dolore lombare cronico), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/70977
Our More Reports:
Chronic Lower Back Pain Market Outlook 2024-2034: Advances in Non-Invasive Treatments and Personalized Care Drive Market Growth
Introduction
Chronic lower back pain (CLBP) is one of the most common and debilitating conditions worldwide, affecting millions of individuals and significantly impacting their quality of life. Defined as pain that persists for more than 12 weeks, CLBP can result from various causes, including degenerative disc disease, muscle strain, sciatica, herniated discs, and spinal stenosis. With the aging population, increased sedentary lifestyles, and growing prevalence of obesity and poor posture, the incidence of CLBP continues to rise, making it a major healthcare concern.
The chronic lower back pain market is expanding rapidly due to the increasing demand for effective treatments and the ongoing advancements in pain management therapies. From non-invasive options such as physical therapy and medications to minimally invasive surgical procedures, the market is witnessing innovations in treatment modalities, driving growth across a wide range of therapeutic options. In addition, with the rise of personalized treatments and interventional techniques, the market is evolving toward more targeted pain management solutions.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/70977
Market Overview
• Market Size 2024: USD 10.2 billion (estimated)
• Forecast 2034: USD 24.5 billion
• CAGR (2024-2034): ~9.1%
The chronic lower back pain market is poised for significant growth, driven by an increase in patient demand for effective pain relief solutions and the rising prevalence of chronic conditions associated with back pain. Additionally, technological advancements in medical devices, surgical interventions, and pain management therapies are improving patient outcomes, enhancing the market's growth prospects. With an increasing focus on non-invasive treatments, personalized therapies, and the adoption of robotic surgeries, the chronic lower back pain market is set to continue expanding through 2034.
Key Growth Drivers
• Growing incidence of chronic lower back pain, driven by aging populations, lifestyle changes, and the rise in sedentary habits.
• Advancements in non-invasive therapies, such as physical therapy, epidural steroid injections, radiofrequency ablation, and transcutaneous electrical nerve stimulation (TENS), which offer effective pain relief with minimal side effects.
• The increasing use of minimally invasive procedures, including robot-assisted surgeries and endoscopic disc surgeries, which offer faster recovery times and reduced surgical risks.
• Personalized treatment approaches, including genetic research, biomarker identification, and patient-specific therapies, are enabling targeted pain management and improving long-term outcomes for individuals with chronic lower back pain.
• Growing demand for combination therapies that integrate pharmacologic, physical therapy, and interventional treatments for enhanced pain relief.
Key Challenges
• High treatment costs, particularly for surgical interventions and advanced medical devices, which may limit access for some patients, especially in developing countries.
• Limited availability of trained professionals and specialized care centers for advanced pain management techniques, hindering access to state-of-the-art treatments.
• Side effects of long-term use of pain medications, including opioids, leading to concerns over dependency, and increasing regulatory pressure on prescribing practices.
• Geographic disparities in healthcare access, particularly in low-income regions or rural areas, where advanced spinal surgery and pain management therapies may not be readily available.
Leading Players
• Medtronic
• AbbVie Inc.
• Johnson & Johnson
• Boston Scientific Corporation
• Stryker Corporation
• GlaxoSmithKline
• Pfizer Inc.
• Baxter International Inc.
• Meda Pharmaceuticals (Mylan)
• Cymedica Orthopedics
These companies are leading the development of medications, medical devices, surgical solutions, and minimally invasive therapies to treat chronic lower back pain. Their focus on clinical trials, regulatory approvals, and global market penetration is driving the growth of the chronic lower back pain market, improving patient outcomes, and offering new pain relief options.
Segmentation Analysis
By Treatment Type
• Medications
o Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
o Opioids (for Severe Pain)
o Muscle Relaxants
o Antidepressants (for Neuropathic Pain)
o Topical Analgesics
• Physical Therapy
o Manual Therapy
o Exercise Therapy
o Posture Correction
o Strengthening Exercises
• Invasive Procedures
o Spinal Injections (Epidural Steroid, Nerve Blocks)
o Radiofrequency Ablation
o Spinal Cord Stimulation (SCS)
• Surgical Treatments
o Minimally Invasive Spine Surgery
o Endoscopic Discectomy
o Spinal Fusion Surgery
o Robotic Spine Surgery
By Platform
• Hospitals & Surgical Centers
• Outpatient Clinics
• Pain Management Centers
• Rehabilitation Clinics
• Home Care Settings (for Physical Therapy & Pain Management)
By Technology
• Robotic-Assisted Surgery
• 3D Imaging (For Spinal Diagnosis and Planning)
• Spinal Cord Stimulation (SCS) Devices
• Low-Level Laser Therapy (LLLT)
• Radiofrequency Technology
By End Use
• Pediatric Patients (Rare Cases of Chronic Lower Back Pain)
• Adult Patients (Most Prevalent in Ages 30-60)
• Geriatric Patients (Due to Osteoarthritis, Degenerative Disc Disease)
By Application
• Degenerative Disc Disease
• Spinal Stenosis
• Herniated Discs
• Sciatica
• Muscle Strain and Ligament Sprains
• Chronic Pain Syndromes (Including Neuropathic Pain)
Summary:
The chronic lower back pain market is primarily segmented into medications, physical therapy, invasive procedures, and surgical treatments. Medications such as NSAIDs and opioids are commonly prescribed for managing pain, while physical therapy plays a key role in rehabilitation. Invasive procedures like spinal injections and radiofrequency ablation offer relief for severe pain, while surgical treatments such as spinal fusion and robotic spine surgery address the root cause of chronic back pain. Robotic-assisted surgery and spinal cord stimulation devices are gaining popularity for their precision and minimally invasive nature.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/70977/chronic-lower-back-pain-market
Regional Insights
North America
• Largest market share, driven by high healthcare expenditure, increasing chronic lower back pain prevalence, and advanced healthcare infrastructure.
• US leads the market, with widespread adoption of minimally invasive procedures and robot-assisted surgeries.
• Growing acceptance of personalized treatments, including spinal cord stimulation and radiofrequency ablation, is driving further growth in the region.
Europe
• Strong market presence in Germany, France, Italy, and the UK, where interventional pain management therapies are becoming standard.
• Increased focus on physical therapy and rehabilitation, with posture correction and strengthening exercises gaining traction across the region.
• Clinical research on robotic-assisted spine surgery and spinal cord stimulation is expanding in Switzerland, Germany, and the UK.
Asia-Pacific
• Fastest-growing market, particularly in China, India, and Japan, driven by the rise in aging populations, increasing healthcare spending, and growing demand for non-invasive treatments.
• China is rapidly expanding healthcare infrastructure and adopting advanced technologies for chronic lower back pain management.
• Japan remains a leader in robot-assisted spine surgery, while India is focusing on affordable pain management solutions for a large population.
Middle East & Africa
• Slow market growth due to limited healthcare access in some regions, although countries like UAE and Saudi Arabia are investing in state-of-the-art pain management solutions.
• South Africa is emerging as a key market for chronic lower back pain management, with increased demand for rehabilitation and non-invasive treatments.
Latin America
• Brazil and Mexico are increasing access to healthcare and improving availability of pain management therapies.
• Economic barriers remain, but private-sector investments are improving access to advanced treatments for chronic pain.
Summary:
North America continues to dominate the chronic lower back pain market, while Asia-Pacific is experiencing rapid growth driven by improving healthcare access and rising demand for non-invasive treatments. Europe is leading in clinical trials and advanced technologies for pain management, while MEA and Latin America are gradually increasing access to chronic pain therapies through public-private collaborations.
Market Dynamics
Key Growth Drivers
• Rising prevalence of chronic lower back pain due to aging populations, sedentary lifestyles, and obesity, leading to a higher demand for pain relief treatments.
• Advancements in non-invasive treatments, such as epidural steroid injections, radiofrequency ablation, and spinal cord stimulation, are providing patients with effective alternatives to surgery.
• Technological innovations in robotic-assisted surgery, 3D imaging, and minimally invasive procedures, which reduce recovery times and improve patient outcomes.
• Growing acceptance of personalized treatments, including tailored pain management and patient-specific interventions, leading to better management of chronic lower back pain.
Key Challenges
• High treatment costs, particularly for advanced procedures such as robot-assisted surgeries and spinal cord stimulation, which may limit accessibility in low-income regions.
• Risk of complications associated with surgical treatments, including infection, nerve damage, and recurrent pain, which may affect patient recovery and long-term outcomes.
• Limited availability of skilled professionals and specialized care centers, especially in rural areas or developing regions, which may delay access to advanced treatments.
Latest Trends
• The increasing use of robotic-assisted surgeries and minimally invasive techniques that enable more precise procedures with shorter recovery times.
• 3D imaging and AI-driven diagnostic tools to personalize chronic pain management, offering more accurate treatment plans based on individual symptoms and clinical data.
• Stem cell therapies and regenerative medicine approaches are emerging as potential solutions for long-term pain relief and joint regeneration in chronic lower back pain patients.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=70977
Competitive Landscape
Key Players
• Medtronic
• AbbVie Inc.
• Johnson & Johnson
• Boston Scientific Corporation
• Stryker Corporation
• GlaxoSmithKline
• Pfizer Inc.
• Baxter International Inc.
• Meda Pharmaceuticals (Mylan)
• Cymedica Orthopedics
Competitive Landscape Analysis:
The chronic lower back pain market is highly competitive, with Medtronic, AbbVie, and Johnson & Johnson leading in pain management devices, robot-assisted spine surgeries, and spinal cord stimulation. Companies like Boston Scientific and Stryker are at the forefront of minimally invasive procedures and implantable devices for pain relief. As demand for non-invasive treatments and personalized pain management grows, competition is expected to intensify, with innovative technologies and AI-driven solutions gaining prominence.
Conclusion
The chronic lower back pain market is expected to grow from USD 10.2 billion in 2024 to USD 24.5 billion by 2034, representing a CAGR of 9.1%.
• Opportunities lie in innovations such as robot-assisted surgeries, personalized pain management, and minimally invasive treatments.
• North America remains the dominant market, while Asia-Pacific is set to experience rapid growth.
• Technological advancements and regenerative medicine will continue to drive market innovation and improve patient outcomes.
With advancements in robot-assisted surgery, minimally invasive treatments, and personalized care, the chronic lower back pain market is set to transform pain management and improve the quality of life for millions of individuals globally.
This report is also available in the following languages : Japanese (慢性腰痛市場), Korean (만성 요통 시장), Chinese (慢性下背痛市场), French (Marché des lombalgies chroniques), German (Markt für chronische Schmerzen im unteren Rücken), and Italian (Mercato del dolore lombare cronico), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/70977
Our More Reports:
Retimer (Redriver)
https://exactitudeconsultancy.com/reports/63782/global-retimer-redriver-market
Handheld Portable Fans
https://exactitudeconsultancy.com/reports/63784/global-handheld-portable-fans-market
Lithium-Ion Battery Pack for Consumer
https://exactitudeconsultancy.com/reports/63786/global-lithium-ion-battery-pack-for-consumer-marke
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Lower Back Pain Market Size, Share and Growth Report, 2034 here
News-ID: 4152233 • Views: …
More Releases from Exactitude Consultancy
Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at …
Introduction
Hypertrophic cardiomyopathy (HCM) is a genetic heart disorder characterized by abnormal thickening of the heart muscle, which can impair blood flow and increase the risk of arrhythmias, heart failure, and sudden cardiac death. Once managed primarily through beta-blockers, calcium channel blockers, and invasive procedures, the HCM treatment landscape has expanded with the approval of targeted therapies such as cardiac myosin inhibitors.
Growing awareness of genetic cardiovascular diseases, advances in molecular diagnostics,…
Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion …
Introduction
Biologics-including monoclonal antibodies, vaccines, recombinant proteins, and advanced therapies-are at the forefront of modern medicine. Their development, however, requires significant expertise, advanced infrastructure, and compliance with stringent regulatory standards. To meet these demands, pharmaceutical and biotechnology companies are increasingly outsourcing to Contract Research Organizations (CROs) specializing in biologics.
Biologics CROs provide services spanning discovery, preclinical research, clinical trials, bioanalytical testing, and regulatory consulting. With the rise of biologics, biosimilars, and advanced…
Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% …
Introduction
Niemann-Pick disease (NPD) is a group of rare, inherited lysosomal storage disorders caused by mutations that disrupt lipid metabolism, leading to progressive neurological decline, organ dysfunction, and premature death. The condition is categorized into several subtypes (A, B, and C), each varying in severity and progression.
Historically, treatment has been limited to palliative and supportive care. However, the landscape is changing rapidly with the development of enzyme replacement therapies (ERT), substrate…
PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: N …
The fight against cancer and neurodegenerative diseases has brought the spotlight on the PERK (Protein kinase RNA-like endoplasmic reticulum kinase) pathway, a critical regulator of the unfolded protein response. PERK inhibitors are designed to modulate this pathway, reducing stress-induced cell death and playing a pivotal role in oncology, neurodegenerative research, and metabolic disorders. As precision medicine continues to gain traction, PERK inhibitors are attracting significant attention from both biotech firms…
More Releases for Pain
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description
Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical…
